دورية أكاديمية
أعرض في EDS

The effect of immediate surgical bipolar plasmakinetic transurethral resection of the prostate on prostatic hyperplasia with acute urinary retention.

التفاصيل البيبلوغرافية
العنوان: The effect of immediate surgical bipolar plasmakinetic transurethral resection of the prostate on prostatic hyperplasia with acute urinary retention.
المؤلفون: He LY, Zhang YC, He JL, Li LX, Wang Y, Tang J, Tan J, Zhong K, Tang YX, Long Z; Department of Urology, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, China.
المصدر: Asian journal of andrology [Asian J Androl] 2016 Jan-Feb; Vol. 18 (1), pp. 134-9.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Shanghai Materia Medica Country of Publication: China NLM ID: 100942132 Publication Model: Print Cited Medium: Internet ISSN: 1745-7262 (Electronic) Linking ISSN: 1008682X NLM ISO Abbreviation: Asian J Androl Subsets: MEDLINE
أسماء مطبوعة: Publication: Shanghai : Shanghai Materia Medica
Original Publication: Beijing : Science Press,
مواضيع طبية MeSH: Prostatic Hyperplasia/*surgery , Transurethral Resection of Prostate/*methods, Acute Disease ; Humans ; Male ; Middle Aged ; Urinary Retention
مستخلص: In the present study, we evaluated the safety and efficacy of immediate surgical bipolar plasmakinetic transurethral resection of the prostate (PK-TURP) for patients with benign prostatic hyperplasia (BPH) with acute urinary retention (AUR). We conducted a retrospective analysis of clinical data of BPH patients who received PK-TURP. A total of 1126 BPH patients were divided into AUR (n = 348) and non-AUR groups (n = 778). After the urethral catheters were removed, the urine white blood cell (WBC) count in the AUR group significantly increased compared with the non-AUR group (P < 0.01). However, there was no significant difference in international prostate symptom score, painful urination, and maximal urinary flow rate. The duration of hospitalization of the AUR group was longer than that of the non-AUR group (P < 0.001). A total of 87.1% (303/348) patients in the AUR group and 84.1% (654/778) patients in the non-AUR group completed all of the postoperative follow-up visits. The incidence of urinary tract infection in the AUR group within 3 months after surgery was significantly higher than that in the non-AUR group (P < 0.01). The incidence of temporary urinary incontinence in the AUR group did not exhibit significant difference. During 3-12 months after surgery, there were no significant differences in major complications between the two groups. Multivariate regression analyses showed that age, postvoid residual, maximal urinary flow rate, diabetes, and hypertension, but not the presence of AUR, were independent predictors of IPSS post-PK-TURP. In conclusion, immediate PK-TURP surgery on patients accompanied by AUR was safe and effective.
References: BJU Int. 2004 Jan;93(1):84-8. (PMID: 14678374)
Ir J Med Sci. 2013 Jun;182(2):207-11. (PMID: 23096424)
Urology. 2013 Jul;82(1):171-5. (PMID: 23561712)
Prostate. 2004 Feb 15;58(3):248-51. (PMID: 14743463)
J Urol. 2004 Jun;171(6 Pt 1):2316-20. (PMID: 15126812)
J Urol. 1989 Feb;141(2):243-7. (PMID: 2643719)
Br J Urol. 1989 Feb;63(2):180-2. (PMID: 2641206)
J Urol. 1992 Jun;147(6):1566-73. (PMID: 1375662)
J Urol. 1997 Aug;158(2):481-7. (PMID: 9224329)
Br J Urol. 1998 May;81(5):712-20. (PMID: 9634047)
BMJ. 1999 Apr 3;318(7188):921-5. (PMID: 10102861)
J Urol. 1999 Oct;162(4):1307-10. (PMID: 10492185)
BJU Int. 2005 Jan;95(1):69-71. (PMID: 15638897)
BJU Int. 2006 Apr;97 Suppl 2:3-6; discussion 21-2. (PMID: 16507045)
BJU Int. 2006 Apr;97(4):727-33. (PMID: 16536763)
J Urol. 2006 Jul;176(1):200-4; discussion 204. (PMID: 16753401)
Eur Urol. 2006 Nov;50(5):969-79; discussion 980. (PMID: 16469429)
J Urol. 2008 Jul;180(1):246-9. (PMID: 18499179)
Urol Int. 2008;81(2):129-34. (PMID: 18758208)
Curr Opin Urol. 2009 Jan;19(1):26-32. (PMID: 19057207)
Urol Int. 2009;83(1):44-8. (PMID: 19641358)
Cochrane Database Syst Rev. 2009;(4):CD006744. (PMID: 19821385)
Int Urol Nephrol. 2010 Mar;42(1):7-12. (PMID: 19449121)
Eur Urol. 2009 Nov;56(5):798-809. (PMID: 19595501)
J Endourol. 2011 Jun;25(6):1043-9. (PMID: 21568691)
Urology. 2011 Nov;78(5):1151-5. (PMID: 21890183)
BJU Int. 2012 Jan;109(1):88-95. (PMID: 22117624)
Urology. 2012 Feb;79(2):397-402. (PMID: 22035765)
Int Urol Nephrol. 2012 Dec;44(6):1593-9. (PMID: 22914880)
BJU Int. 2012 Dec;110(11):1595-601. (PMID: 22540956)
BJU Int. 2012 Dec;110(11 Pt C):E896-901. (PMID: 23035623)
J Urol. 2002 Jan;167(1):5-9. (PMID: 11743263)
تواريخ الأحداث: Date Created: 20150717 Date Completed: 20160926 Latest Revision: 20220331
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC4736342
DOI: 10.4103/1008-682X.157395
PMID: 26178398
قاعدة البيانات: MEDLINE
الوصف
تدمد:1745-7262
DOI:10.4103/1008-682X.157395